U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07702669) titled 'Modified Huanglian Wendan Decoction for Metabolic Syndrome' on July 09.
Brief Summary: This randomized controlled clinical study aims to evaluate the effect of Modified Huanglian Wendan Decoction on oxidative stress in patients with metabolic syndrome. A total of 180 patients with metabolic syndrome from The First Affiliated Hospital of Heilongjiang University of Chinese Medicine will be assigned to a control group or an observation group at a 1:1 ratio. Participants in both groups will receive lifestyle intervention and standard therapy, including antihypertensive, hypoglycemic, and lipid-lowering treatment. Participants in the obs...